JANUX THERAPEUTICS INC (JANX:NASDAQ)
$15.46 -0.41 (-2.5835%)
Analysed JANUX THERAPEUTICS INC (JANX:NASDAQ) News Sources
Lilly’s obesity pill off to a strong start; OpenAI debuts new drug discovery tool
17-04-2026
biopharmadive.com
Janux Therapeutics Announces First Participant Dosed in Phase 1 Study of JANX014
16-04-2026
yahoo.com
Will Health Benefits Weakness Drag Elevance's Q1 Earnings?
16-04-2026
yahoo.com
Sector Update: Health Care Stocks Decline Late Afternoon
15-04-2026
yahoo.com
Sector Update: Health Care Stocks Lower in Afternoon Trading
15-04-2026
yahoo.com
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Align Technology, American Tower, Autodesk, Autoliv, Chime Financial, Cloudflare, SolarEdge Technologies, Zoetis, and More
15-04-2026
247wallst.com
Bristol-Myers Squibb Cancer Moves And Equity Efforts Underpin Valuation Case
03-04-2026
yahoo.com
Janux Therapeutics Secures $35M Milestone Payment From BMY Deal
02-04-2026
yahoo.com
Janux Therapeutics Announces Development Candidate Nomination Under Bristol Myers Squibb Collaboration, Triggering $35 Million Milestone Payment
01-04-2026
yahoo.com
Janux Therapeutics, Inc. (JANX) Commences Patient Dosing of JANX011 in Autoimmune Trial
02-03-2026
yahoo.com
What is the current price of JANUX THERAPEUTICS INC (JANX:NASDAQ)?
The current price of JANUX THERAPEUTICS INC (JANX:NASDAQ) is $15.46.
JANUX THERAPEUTICS INC (JANX:NASDAQ) absolute price change since previous trading day?
The absolute price change of JANUX THERAPEUTICS INC (JANX:NASDAQ) since the previous trading day is $-0.41.
JANUX THERAPEUTICS INC (JANX:NASDAQ) percentage price change since previous trading day?
The percentage price change of JANUX THERAPEUTICS INC (JANX:NASDAQ) since the previous trading day is -2.5835%.
What is the most recent average sentiment score for JANUX THERAPEUTICS INC (JANX:NASDAQ)?
The most recent average sentiment score for JANUX THERAPEUTICS INC (JANX:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for JANUX THERAPEUTICS INC (JANX:NASDAQ)?
The most recent sentiment for JANUX THERAPEUTICS INC (JANX:NASDAQ) is .
SEC-8K** Filing Available For JANUX THERAPEUTICS INC (JANX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.